In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.
Researchers are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research.
Even relatively low doses of resveratrol—a chemical found in the skins of red grapes and in red wine—can improve the sensitivity of mice to the hormone insulin, according to a report in the October issue of Cell Metabolism, a Cell Press publication.
The Alternate Healthy Eating Index measures and compares factors in a person’s diet that are strongly linked to reducing risk for cardiovascular disease. According to researchers at the University of Massachusetts who compared the dietary quality of several popular weight-loss plans, none of the plans achieved a perfect AHEI score, “but the Ornish, Weight Watchers high-carbohydrate and New Glucose Revolution plans were among the best performers using the AHEI and traditional dietary quality assessments.”
A glitch in the production and folding of molecules deep within the insulin-producing cells of the pancreas may be responsible for the death of those cells and the onset of diabetes, new animal research suggests.
A new Joslin-led study has shown that leptin, a hormone known mainly for regulating appetite control and energy metabolism, plays a major role in islet cell growth and insulin secretion. This finding opens up new avenues for studying leptin and its role in islet cell biology, which may lead to new treatments for diabetes.
Amylin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the SymlinPen(TM) 120 and the SymlinPen(TM) 60 pen-injector devices for administering SYMLIN(R) (pramlintide acetate) injection.
Over the past three decades, the rising obesity epidemic has been accompanied by a proliferation of weight-loss plans. However, as a new study by researchers from the University of Massachusetts Medical School (UMMS) reveals, these weight-loss plans vary significantly in their ability to positively affect heart health.
A lower metabolism, as well as slight changes in eating behavior, could explain the positive energy balance leading to being overweight in narcolepsy, according to a study published in the October 1 issue of the journal SLEEP.
Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.